Di Nisio Marcello, Porreca Ettore, Di Donato Valeria, Tiboni Gian Mario
Department of Medical, Oral and Biotechnological Sciences, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy ; Department of Vascular Medicine, Academic Medical Center, Amsterdam, Netherlands.
Department of Medicine and Aging, University "G. D'Annunzio" of Chieti-Pescara, Chieti, Italy.
J Ovarian Res. 2014 May 22;7:58. doi: 10.1186/1757-2215-7-58. eCollection 2014.
The activation of blood coagulation could contribute to the failure of in-vitro fertilization (IVF) techniques. The aim of this study was to assess the predictive value of D-dimer levels for pregnancy outcome in women undergoing IVF.
A prospective study was performed in 105 women undergoing IVF. D-dimer was measured before and one week after the administration of recombinant human chorionic gonadotropin (r-hCG). The primary outcome of the study was clinical pregnancy. The mean age was 36 years (range 26 to 43 years). The main indications for IVF were infertility due to a tubaric (n = 21, 20%) or male factor (n = 37, 35%) and idiopathic infertility (n = 30, 29%) which altogether accounted for 84% of the total. Clinical pregnancy was achieved by 40/105 (38%) women of whom 32 (80%) delivered a live child. On the day of r-hCG administration, D-dimer concentrations were significantly higher in patients not achieving a clinical pregnancy (141 ng/dL vs. 115 ng/dL, p = 0.035) which remained statistically significant after correction for age and indications for IVF in multivariable analysis (p = 0.032). One week after r-hCG, the levels of D-dimer were significantly increased both in women with and without a clinical pregnancy with no differences between the groups (748 ng/dL vs. 767 ng/dL, p = 0.88).
D-dimer concentrations seem to predict a higher risk of pregnancy failure in women undergoing IVF. If confirmed in future prospective studies, D-dimer could help identifying a group of patients who could benefit from prophylaxis to increase the pregnancy success rate.
血液凝固的激活可能导致体外受精(IVF)技术失败。本研究的目的是评估D-二聚体水平对接受IVF的女性妊娠结局的预测价值。
对105名接受IVF的女性进行了一项前瞻性研究。在注射重组人绒毛膜促性腺激素(r-hCG)之前和之后一周测量D-二聚体。该研究的主要结局是临床妊娠。平均年龄为36岁(范围26至43岁)。IVF的主要指征是输卵管因素导致的不孕(n = 21,20%)或男性因素导致的不孕(n = 37,35%)以及特发性不孕(n = 30,29%),这些因素总计占总数的84%。105名女性中有40名(38%)实现了临床妊娠,其中32名(80%)分娩了活产婴儿。在注射r-hCG当天,未实现临床妊娠的患者D-二聚体浓度显著更高(141 ng/dL对115 ng/dL,p = 0.035),在多变量分析中校正年龄和IVF指征后,这一差异仍具有统计学意义(p = 0.032)。注射r-hCG一周后,无论有无临床妊娠,女性的D-二聚体水平均显著升高,两组之间无差异(748 ng/dL对767 ng/dL,p = 0.88)。
D-二聚体浓度似乎可以预测接受IVF的女性妊娠失败的风险较高。如果在未来的前瞻性研究中得到证实,D-二聚体可能有助于识别一组可以从预防措施中获益以提高妊娠成功率的患者。